Drug Company Hit With Shareholder Suit Over Proposed Merger Deal
BOSTON — A pharmaceutical company and its board of directors issued a proxy statement in connection with a proposed merger deal that contained several misrepresentations and omitted important facts surrounding the...To view the full article, register now.
Already a subscriber? Click here to view full article